AIDS economic impact has hefty tab

September 22, 2006

The estimated economic cost of HIV and AIDS in the United States is about $36.4 billion annually, federal government researchers say.

That figure is far more than believed earlier, the Atlanta-based Centers for Disease Control and Prevention said in a report.

More than 80 percent of that tab, based on those people infected in 2002, is related to productivity losses, a cost that most previous studies have omitted, the CDC said.

Minorities incur fewer direct medical costs than whites but suffer greater financial damage from lost productivity, the report said.

An estimated 40,000 people in the United States are infected with HIV each year.

Based on the work of researchers from CDC and Emory and Georgia State universities, the report was published on-line in the Journal of Acquired Immune Deficiency Syndromes, ahead of print publication.

Copyright 2006 by United Press International

Explore further: Schistosoma vaccine to enter phase Ib clinical trial

Related Stories

Schistosoma vaccine to enter phase Ib clinical trial

January 18, 2018
Researchers at Baylor College of Medicine, in collaboration with a team of researchers at the George Washington University and the Rene Rachou Institute, have received funding from the National Institutes of Health for a ...

This year's severe flu exposes a serious flaw in our medical system

January 18, 2018
Flu season in the U.S. typically peaks in February, but this year's outbreak is already one of the worst on record. As of Jan. 6, 20 children have died from the flu, and overall mortality caused by the flu is already double ...

Dietary sugar linked to increasing bacterial epidemics

January 3, 2018
The increasing frequency and severity of healthcare-associated outbreaks caused by bacterium Clostridium difficile have been linked to the widely used food additive trehalose. A team of researchers discovered that in laboratory ...

Strategy introduces stable components of flu virus for long-lasting, DNA-enhanced protection

January 5, 2018
Getting a flu shot every year can be a pain. One UW Medicine researcher is hoping to make the yearly poke a thing of the past with the development of a universal vaccine that would protect from all strains of influenza virus, ...

Why the US is 'the most dangerous of wealthy nations for a child to be born into'

January 12, 2018
It's no surprise that the United States ranks absolutely last in child mortality among the world's wealthiest countries—that's been true for years. A new study examines how this sad situation came to be.

Blood banks need January donors

January 9, 2018
(HealthDay)—Want to make a difference right now? Consider donating some blood.

Recommended for you

HIV-1 genetic diversity is higher in vaginal tract than in blood during early infection

January 18, 2018
A first-of-its-kind study has found that the genetic diversity of human immunodeficiency virus type 1 (HIV-1) is higher in the vaginal tract than in the blood stream during early infection. This finding, published in PLOS ...

War in Ukraine has escalated HIV spread in the country: study

January 15, 2018
Conflict in Ukraine has increased the risk of HIV outbreaks throughout the country as displaced HIV-infected people move from war-affected regions to areas with higher risk of transmission, according to analysis by scientists.

Researchers offer new model for uncovering true HIV mortality rates in Zambia

January 12, 2018
A new study that seeks to better ascertain HIV mortality rates in Zambia could provide a model for improved national and regional surveillance approaches, and ultimately, more effective HIV treatment strategies.

New drug capsule may allow weekly HIV treatment

January 9, 2018
Researchers at MIT and Brigham and Women's Hospital have developed a capsule that can deliver a week's worth of HIV drugs in a single dose. This advance could make it much easier for patients to adhere to the strict schedule ...

New long-acting, less-toxic HIV drug suppresses virus in humanized mice

January 8, 2018
A team of Yale researchers tested a new chemical compound that suppresses HIV, protects immune cells, and remains effective for weeks with a single dose. In animal experiments, the compound proved to be a promising new candidate ...

Usage remains low for pill that can prevent HIV infection

January 8, 2018
From gritty neighborhoods in New York and Los Angeles to clinics in Kenya and Brazil, health workers are trying to popularize a pill that has proven highly effective in preventing HIV but which—in their view—remains woefully ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.